Hythiam (HYTM) Selected By Ford (F) for Catasys Integrated Substance Dependence Solution

September 17, 2009 8:22 AM EDT

Hythiam, Inc. (NASDAQ: HYTM) has entered into a three year agreement with Ford Motor Company (NYSE: F) to provide the Catasys integrated substance dependence solution to Ford’s hourly employees in Michigan enrolled in the National PPO and who meet certain criteria.

Eligible employees struggling with alcoholism, stimulant and opiate dependence will be covered under the program, which contains medical interventions including naltrexone, Suboxone® and the proprietary PROMETA® Treatment Program, and psychosocial and care coaching components across 52 weeks. The Company will conduct direct outreach to enroll qualified members, and will also work with UAW-Ford and Ford’s EAP program to ensure the most beneficial treatment pathway for members. Contractual revenues from the agreement are based on a combination of monthly fees for the member population for Catasys, with additional monthly fees for members enrolled into the Catasys program. Operational implementation is expected to begin shortly, and the program is anticipated to launch in the fourth quarter of 2009.


Related Categories

Corporate News
Momentum Movers

Stocks Mentioned

F 11.10

+0.13 +1.19%
Volume: 67,331,964
Track F

HYTM 0.41

-0.01 -2.38%
Volume: 160,535
Track HYTM


Add Your Comment





Follow StreetInsider.com On Twitter